[go: up one dir, main page]

HUP2300199A1 - Benzofurán-3-karbonsavamidok és benzofurán-3-karbonil-benzamidok, eljárás ezek nagy szelektivitással történõ elõállítására, valamint az ezeket tartalmazó gyógyszerkészítmények - Google Patents

Benzofurán-3-karbonsavamidok és benzofurán-3-karbonil-benzamidok, eljárás ezek nagy szelektivitással történõ elõállítására, valamint az ezeket tartalmazó gyógyszerkészítmények

Info

Publication number
HUP2300199A1
HUP2300199A1 HU2300199A HUP2300199A HUP2300199A1 HU P2300199 A1 HUP2300199 A1 HU P2300199A1 HU 2300199 A HU2300199 A HU 2300199A HU P2300199 A HUP2300199 A HU P2300199A HU P2300199 A1 HUP2300199 A1 HU P2300199A1
Authority
HU
Hungary
Prior art keywords
benzofuran
carbonylbenzamides
preparation
carboxylic acid
pharmaceutical compositions
Prior art date
Application number
HU2300199A
Other languages
English (en)
Inventor
Kollar Laszlo Dr
Nagymihaly Zoltan Dr
Gallyas Ferenc Dr
Original Assignee
Pecsi Tudomanyegyetem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pecsi Tudomanyegyetem filed Critical Pecsi Tudomanyegyetem
Priority to HU2300199A priority Critical patent/HUP2300199A1/hu
Priority to PCT/HU2024/050044 priority patent/WO2024261504A1/en
Publication of HUP2300199A1 publication Critical patent/HUP2300199A1/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80Radicals substituted by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU2300199A 2023-06-21 2023-06-21 Benzofurán-3-karbonsavamidok és benzofurán-3-karbonil-benzamidok, eljárás ezek nagy szelektivitással történõ elõállítására, valamint az ezeket tartalmazó gyógyszerkészítmények HUP2300199A1 (hu)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU2300199A HUP2300199A1 (hu) 2023-06-21 2023-06-21 Benzofurán-3-karbonsavamidok és benzofurán-3-karbonil-benzamidok, eljárás ezek nagy szelektivitással történõ elõállítására, valamint az ezeket tartalmazó gyógyszerkészítmények
PCT/HU2024/050044 WO2024261504A1 (en) 2023-06-21 2024-06-20 Benzofuran-3-carboxylic acid amides and benzofuran-3- carbonyl-benzamides, method for their production with high selectivity, and pharmaceutical compositions containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU2300199A HUP2300199A1 (hu) 2023-06-21 2023-06-21 Benzofurán-3-karbonsavamidok és benzofurán-3-karbonil-benzamidok, eljárás ezek nagy szelektivitással történõ elõállítására, valamint az ezeket tartalmazó gyógyszerkészítmények

Publications (1)

Publication Number Publication Date
HUP2300199A1 true HUP2300199A1 (hu) 2024-12-28

Family

ID=93934984

Family Applications (1)

Application Number Title Priority Date Filing Date
HU2300199A HUP2300199A1 (hu) 2023-06-21 2023-06-21 Benzofurán-3-karbonsavamidok és benzofurán-3-karbonil-benzamidok, eljárás ezek nagy szelektivitással történõ elõállítására, valamint az ezeket tartalmazó gyógyszerkészítmények

Country Status (2)

Country Link
HU (1) HUP2300199A1 (hu)
WO (1) WO2024261504A1 (hu)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2599987A1 (en) * 2005-03-03 2006-09-08 Sirtris Pharmaceuticals, Inc. Fused heterocyclic compounds and their use as sirtuin modulators
PE20121506A1 (es) * 2006-07-14 2012-11-26 Amgen Inc Compuestos triazolopiridinas como inhibidores de c-met
US20130072473A1 (en) * 2011-05-09 2013-03-21 Proteostasis Therapeutics, Inc. Compounds for treating protein folding disorders

Also Published As

Publication number Publication date
WO2024261504A1 (en) 2024-12-26

Similar Documents

Publication Publication Date Title
HUE071190T2 (hu) Terner egykristályos pozitív elektróda anyag, elõállítási eljárása és alkalmazása
FR3037956B1 (fr) Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
Cai et al. 14-Deoxy-11, 12-dehydroandrographolide exerts anti-influenza A virus activity and inhibits replication of H5N1 virus by restraining nuclear export of viral ribonucleoprotein complexes
EP3719126A4 (en) NUCLEIC ACID, COMPOSITION AND CONJUGATE WITH NUCLEIC ACID, METHOD FOR THEIR PRODUCTION AND USE
HUE061758T2 (hu) Új hidroxisav-származékok, eljárás elõállításukra és ezeket tartalmazó gyógyszerkészítmények
BR112014028841A2 (pt) processo para preparação de n-[5-(3,5-difluoro-benzil)-1h-indazol-3-il]-4-(4-metil-piperazin-l-il)-2-(tetra-hidro-piran-4-ilamino)-benzamida
WO2019215063A8 (en) Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
EP3351242A4 (en) CANNABINOID-HOLDING ORAL PHARMACEUTICAL COMPOSITION, PROCESS FOR THE PREPARATION AND USE THEREOF
MA37206B1 (fr) Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PE20030527A1 (es) Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
EA201892838A1 (ru) Новые пиперидинильные производные, способ их получения и фармацевтические композиции, содержащие их
FR3046792B1 (fr) Nouveaux derives d'ammonium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BR112019000089A2 (pt) variante de xilanase, composição, grânulo, aditivo de ração animal, formulação líquida, ração animal, métodos para aprimorar um ou mais parâmetros de desempenho de um animal, para solubilizar xilana a partir do material à base de planta, para liberar amido do material à base de planta, para aprimorar o valor nutricional de uma ração animal, para preparar uma massa ou um produto assado preparado a partir da massa, de produção de uma variante de xilanase e para obter uma variante de xilanase, uso de uma variante de xilanase, processo de produção de um produto de fermentação, polinucleotídeo isolado, construto de ácido nucleico ou vetor de expressão, e, célula hospedeira recombinante.
TN2012000266A1 (fr) Nouveaux co-cristaux d'agomelatine, leur procede de preparation et les compositions pharmaceutiques qui les contiennet
EA201791537A1 (ru) Фармацевтическая композиция на основе наночастиц доцетаксела-альбумина, способ ее получения и ее применение
EP3946697C0 (en) CREATINE/CREATINE BIOSENSORS COMPRISING OUTER MEMBRANE COMPOSITIONS
EP3766521A4 (en) PHARMACEUTICAL COMPOSITION WITH 211AT-LABELED AMINO ACID DERIVATIVE AND PROCESS FOR PREPARING THIS PHARMACEUTICAL COMPOSITION
HUP2300199A1 (hu) Benzofurán-3-karbonsavamidok és benzofurán-3-karbonil-benzamidok, eljárás ezek nagy szelektivitással történõ elõállítására, valamint az ezeket tartalmazó gyógyszerkészítmények
PH12020500278A1 (en) Pharmaceutical composition and method for preparing same
BR112019000521A2 (pt) forma de cristal de intermediário de dapagliflozina e método de preparação do mesmo
MX382563B (es) Formas cristalinas de bilastina y procedimientos para su preparacion.
EP4071170A4 (en) PHARMACEUTICAL COMPOSITION, MANUFACTURING PROCESS THEREOF AND USE THEREOF
BR112019000187A2 (pt) composição sólida contendo anticoagulante oral
MX395187B (es) Formulación farmacéutica para la administración oral con uniformidad del cóntenido mejorada, que comprende perlas de liberación sostenida que contienen hidrocloruro de tamsulosina.
EA201391734A1 (ru) Хондроитинсульфат акульего типа и способ его получения

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished